32
In band
Moving averages
SMA 200$5.03-53.88%
Company profile
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$137.99M
P/E ratioNone
EPS$-36.12
Beta-0.118
Dividend yield0.00%
52-week high$12.46
52-week low$2.39
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
CHRS
Coherus Biosciences Inc
RSI 34
SAVA
Cassava Sciences Inc
DTIL
Precision Biosciences Inc
RSI 56
IMUX
Immunic Inc
RSI 40
IVVD
Invivyd Inc
RSI 37
TRDA
Entrada Therapeutics Inc
RSI 41
RSI alerts for NERV
An email when NERV closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:39 PM EDT